Area of Science:

• Public Health
• Pharmacology
• Drug Safety

Background:

• Sub-Saharan Africa faces significant public health challenges, including malaria and HIV/AIDS.
• Large-scale deployment of new medicines in the region over the past two decades has raised concerns about drug toxicity.
• Adverse drug reactions can lead to reduced treatment compliance and discontinuation, impacting public health outcomes.

Purpose of the Study:

• To assess the performance of pharmacovigilance systems in Sub-Saharan Africa.
• To identify areas for improvement in drug safety monitoring in Burkina Faso.
• To propose strategies for strengthening pharmacovigilance in the region.

Main Methods:

• Review of pharmacovigilance activities initiated in Burkina Faso in 2008.
• Analysis of the current performance level of existing pharmacovigilance systems.
• Identification of key areas for system enhancement.

Main Results:

• Pharmacovigilance activities were established in Burkina Faso in 2008.
• Current pharmacovigilance systems in Burkina Faso have not yet reached optimal performance.
• Significant challenges remain in effectively managing drug-related health issues.

Conclusions:

• Pharmacovigilance systems in Burkina Faso require strengthening to effectively address drug safety concerns.
• Key areas for improvement include health worker training, active surveillance, public awareness, and national coordination.
• Enhanced pharmacovigilance is crucial for ensuring the safe and effective deployment of medicines in the region.